Age of walking and intellectual ability in autism spectrum disorder and other neurodevelopmental disorders: a population-based study.


Journal

Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361

Informations de publication

Date de publication:
09 2021
Historique:
accepted: 23 11 2020
pubmed: 29 12 2020
medline: 27 10 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Delayed walking is common in intellectual disability (ID) but may be less common when ID occurs with autism spectrum disorder (ASD). Previous studies examining this were limited by reliance on clinical samples and exclusion of children with severe motor deficits. To examine in a population-based sample if age of walking is differentially related to intellectual ability in children with ASD versus other neurodevelopmental disorders (NDD). Participants were from the nested Autism Birth Cohort Study of the Norwegian Mother, Father and Child Cohort Study (MoBa). Cox proportional hazards regression assessed if diagnosis (ASD n = 212 vs. NDD n = 354), continuous nonverbal IQ, and their interaction, were associated with continuous age of walking. The relationship between nonverbal IQ and age of walking was stronger for NDD than for ASD (Group × nonverbal IQ interaction, χ The finding that age of walking is less strongly related to low intellectual ability in children with ASD than in children without other NDDs supports the hypothesis that ID in ASD may result from heterogeneous developmental pathways. Late walking may be a useful stratification variable in etiological research focused on ASD and other NDDs.

Sections du résumé

BACKGROUND
Delayed walking is common in intellectual disability (ID) but may be less common when ID occurs with autism spectrum disorder (ASD). Previous studies examining this were limited by reliance on clinical samples and exclusion of children with severe motor deficits.
OBJECTIVE
To examine in a population-based sample if age of walking is differentially related to intellectual ability in children with ASD versus other neurodevelopmental disorders (NDD).
METHODS
Participants were from the nested Autism Birth Cohort Study of the Norwegian Mother, Father and Child Cohort Study (MoBa). Cox proportional hazards regression assessed if diagnosis (ASD n = 212 vs. NDD n = 354), continuous nonverbal IQ, and their interaction, were associated with continuous age of walking.
RESULTS
The relationship between nonverbal IQ and age of walking was stronger for NDD than for ASD (Group × nonverbal IQ interaction, χ
CONCLUSIONS
The finding that age of walking is less strongly related to low intellectual ability in children with ASD than in children without other NDDs supports the hypothesis that ID in ASD may result from heterogeneous developmental pathways. Late walking may be a useful stratification variable in etiological research focused on ASD and other NDDs.

Identifiants

pubmed: 33369747
doi: 10.1111/jcpp.13369
pmc: PMC8236490
mid: NIHMS1695925
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1070-1078

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD093012
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12013/1
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : ZIC MH002961
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : U01 NS047537
Pays : United States

Informations de copyright

© 2020 Association for Child and Adolescent Mental Health.

Références

Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):E1859-E1866
pubmed: 29434036
Lang Cogn Process. 2001 Apr 1;16(2-3):287-308
pubmed: 16703115
Int J Epidemiol. 2006 Oct;35(5):1146-50
pubmed: 16926217
J Autism Dev Disord. 2015 Apr;45(4):966-74
pubmed: 25239176
J Consult Clin Psychol. 2007 Aug;75(4):594-604
pubmed: 17663613
PLoS One. 2019 Mar 28;14(3):e0214475
pubmed: 30921424
J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):538-549
pubmed: 16601400
Mol Psychiatry. 2010 Jul;15(7):676-80
pubmed: 20571529
Child Dev. 2013 Mar-Apr;84(2):429-42
pubmed: 23110514
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730
Child Neuropsychol. 2016;22(5):556-69
pubmed: 25833070
Pediatrics. 2013 Jun;131(6):e2016-27
pubmed: 23713113
Early Hum Dev. 2015 Jul;91(7):393-400
pubmed: 25981493
J Consult Clin Psychol. 2012 Jun;80(3):477-89
pubmed: 22506796
Percept Mot Skills. 1995 Apr;80(2):547-52
pubmed: 7675588
Neuron. 2010 Oct 21;68(2):192-5
pubmed: 20955926
Autism. 2018 Oct;22(7):891-896
pubmed: 28903580
J Child Psychol Psychiatry. 2011 Jul;52(7):753-60
pubmed: 21410473
J Am Acad Child Adolesc Psychiatry. 2014 Feb;53(2):237-57
pubmed: 24472258
J Child Psychol Psychiatry. 2017 Oct;58(10):1092-1105
pubmed: 28921543
J Clin Psychiatry. 2005;66 Suppl 10:3-8
pubmed: 16401144
Arch Dis Child. 2017 Nov;102(11):1071-1076
pubmed: 29054862
J Am Acad Child Adolesc Psychiatry. 2018 Nov;57(11):849-857.e2
pubmed: 30392626
J Am Acad Child Adolesc Psychiatry. 2002 May;41(5):604-12
pubmed: 12014793
Autism Res. 2019 May;12(5):700-714
pubmed: 31025542
Paediatr Perinat Epidemiol. 2013 Nov;27(6):553-63
pubmed: 23919580
Am J Public Health. 1983 Sep;73(9):1094-6
pubmed: 6881409
Pediatrics. 2015 Oct;136 Suppl 1:S60-81
pubmed: 26430170
Pediatrics. 2016 Mar;137(3):e20152959
pubmed: 26908679
Biol Psychiatry. 2007 Feb 15;61(4):438-48
pubmed: 17276746
Ann Neurol. 2007 Aug;62(2):128-36
pubmed: 17487877
Nat Genet. 2017 Jul;49(7):978-985
pubmed: 28504703
Age (Dordr). 2015 Jun;37(3):9785
pubmed: 25929653
J Autism Dev Disord. 2020 Sep;50(9):3216-3232
pubmed: 31278523
Early Hum Dev. 2000 Sep;59(3):159-73
pubmed: 10996272
Am J Psychiatry. 2017 Jun 1;174(6):576-585
pubmed: 28253736
Am J Med Genet C Semin Med Genet. 2015 Jun;169(2):198-208
pubmed: 25959391
Matern Child Nutr. 2013 Jan;9 Suppl 1:89-104
pubmed: 23167587
J Child Psychol Psychiatry. 2014 Dec;55(12):1354-62
pubmed: 24889883
J Speech Lang Hear Res. 2018 Nov 8;61(11):2615-2628
pubmed: 30418491
PLoS One. 2016 Apr 25;11(4):e0153655
pubmed: 27110944
J Autism Dev Disord. 2016 May;46(5):1847-59
pubmed: 26820632
Pediatrics. 2014 Sep;134(3):e903-18
pubmed: 25157020
Int J Epidemiol. 2016 Apr;45(2):382-8
pubmed: 27063603
J Child Psychol Psychiatry. 2007 Sep;48(9):932-40
pubmed: 17714378
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Psychiatr Danub. 2009 Sep;21(3):310-9
pubmed: 19794347
Dev Med Child Neurol. 2005 Sep;47(9):581-6
pubmed: 16138663
Am J Intellect Dev Disabil. 2013 Mar;118(2):156-76
pubmed: 23464612
Neurosci Biobehav Rev. 2017 Sep;80:382-393
pubmed: 28642071
Am J Psychiatry. 1989 Feb;146(2):194-9
pubmed: 2783539
Biol Psychiatry. 2008 Oct 1;64(7):549-51
pubmed: 18778978
Curr Dev Disord Rep. 2017;4(4):137-144
pubmed: 29188169
BJPsych Open. 2019 May 17;5(3):e41
pubmed: 31530312
Front Psychiatry. 2019 Jul 30;10:526
pubmed: 31417436
Neurosci Biobehav Rev. 2019 May;100:296-304
pubmed: 30885812

Auteurs

Alexandra Havdahl (A)

Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway.
Norwegian Institute of Public Health, Oslo, Norway.
MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway.

Cristan Farmer (C)

Pediatrics & Developmental Neuroscience Branch, National Institute of Mental Health, Bethesda, MD, USA.

Synnve Schjølberg (S)

Norwegian Institute of Public Health, Oslo, Norway.

Anne-Siri Øyen (AS)

Nic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway.
Norwegian Institute of Public Health, Oslo, Norway.

Pål Surén (P)

Norwegian Institute of Public Health, Oslo, Norway.

Ted Reichborn-Kjennerud (T)

Norwegian Institute of Public Health, Oslo, Norway.

Per Magnus (P)

Norwegian Institute of Public Health, Oslo, Norway.

Michaeline Bresnahan (M)

New York State Psychiatric Institute, Columbia University Medical Center, New York, NY, USA.
Department of Epidemiology, Mailman School of Public Health, New York, NY, USA.

Mady Hornig (M)

Department of Epidemiology, Mailman School of Public Health, New York, NY, USA.

Ezra Susser (E)

New York State Psychiatric Institute, Columbia University Medical Center, New York, NY, USA.
Department of Epidemiology, Mailman School of Public Health, New York, NY, USA.

W Ian Lipkin (WI)

Department of Epidemiology, Mailman School of Public Health, New York, NY, USA.
Center for Infection and Immunity, Mailman School of Public Health and Departments of Neurology and Pathology, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY, USA.

Catherine Lord (C)

David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Camilla Stoltenberg (C)

Norwegian Institute of Public Health, Oslo, Norway.
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Audrey Thurm (A)

Pediatrics & Developmental Neuroscience Branch, National Institute of Mental Health, Bethesda, MD, USA.

Somer Bishop (S)

UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH